PIOMBINO DESE, Italy, September 08, 2026--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in two upcoming investor conferences:
Tuesday, September 15, at 1:50 p.m. (ET) – Morgan Stanley Annual Global Healthcare Conference, New York, NY
Tuesday, September 22, at 8:25 – 9:05 a.m. (GMT) – BofA Global Healthcare Conference, London, UK
A live webcast for each event will be available on the Company's website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients.
For more information, please visit: www.stevanatogroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908397502/en/
Contacts
Media
Stevanato Group
[email protected]
Investor Relations
Lisa Miles
[email protected]
Giacomo Guiducci
[email protected]